
FLT3-IN-4
CAS No. 2304799-09-3
FLT3-IN-4( —— )
Catalog No. M32925 CAS No. 2304799-09-3
FLT3-IN-4 (FLT3 inhibitor 9u) is a potent and orally effective Fms-like tyrosine receptor kinase 3 (FLT3;?IC50=7 nM) inhibitor ,for treating acute myelogenous leukemia.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 143 | Get Quote |
![]() ![]() |
5MG | 226 | Get Quote |
![]() ![]() |
10MG | 335 | Get Quote |
![]() ![]() |
25MG | 522 | Get Quote |
![]() ![]() |
50MG | 707 | Get Quote |
![]() ![]() |
100MG | 888 | Get Quote |
![]() ![]() |
500MG | 1782 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameFLT3-IN-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionFLT3-IN-4 (FLT3 inhibitor 9u) is a potent and orally effective Fms-like tyrosine receptor kinase 3 (FLT3;?IC50=7 nM) inhibitor ,for treating acute myelogenous leukemia.
-
DescriptionFLT3-IN-4 is a potent and orally effective Fms-like tyrosine receptor kinase 3 (FLT3; IC50=7 nM) inhibitor for treating acute myelogenous leukemia.
-
In VitroFLT3-IN-4 (Compound 9u) shows potent inhibitory activities against MV4-11 and Molm-13 cells with IC50 values are 0.089±0.001 nM and 0.022±0.003 nM, respectively.
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFLT
-
RecptorFLT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2304799-09-3
-
Formula Weight431.49
-
Molecular FormulaC23H25N7O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (57.94 mM; Ultrasonic )
-
SMILESCC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CC=C)c3ncnc(N)c23)no1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yuan X, et al. Identification of Pyrrolo[2,3- d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous Leukemia. J Med Chem. 2019 Apr 25;62(8):4158-4173.?
molnova catalog



related products
-
5'-Fluoroindirubinox...
5'-Fluoroindirubinoxime is a potent FLT3 inhibitor( IC50 : 15 nM).
-
HM43239
HM43239 is a selective FLT3 inhibitor (IC50s: 1.1 nM for FLT3 WT, 1.8 nM for FLT3 ITD, and 1.0 nM for FLT3 D835Y kinases, respectively).
-
4SC-203
4SC-203 is a multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs).